BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $232,310 | +14.3% | 5,099 | +1.8% | 0.04% | +5.4% |
| Q1 2023 | $203,206 | -25.0% | 5,010 | -5.7% | 0.04% | -24.5% |
| Q4 2022 | $270,906 | -5.3% | 5,315 | 0.0% | 0.05% | -18.3% |
| Q3 2022 | $286,000 | -16.1% | 5,315 | 0.0% | 0.06% | -14.3% |
| Q2 2022 | $341,000 | -17.2% | 5,315 | 0.0% | 0.07% | -1.4% |
| Q1 2022 | $412,000 | -14.5% | 5,315 | -5.4% | 0.07% | -16.5% |
| Q4 2021 | $482,000 | +3.4% | 5,620 | -3.1% | 0.08% | +13.3% |
| Q3 2021 | $466,000 | -2.9% | 5,798 | -2.7% | 0.08% | -1.3% |
| Q2 2021 | $480,000 | -4.6% | 5,960 | -1.0% | 0.08% | -13.6% |
| Q1 2021 | $503,000 | +3.5% | 6,019 | -0.5% | 0.09% | +17.3% |
| Q4 2020 | $486,000 | -6.5% | 6,051 | -6.3% | 0.08% | -25.7% |
| Q3 2020 | $520,000 | -8.0% | 6,460 | -1.5% | 0.10% | -12.2% |
| Q2 2020 | $565,000 | +6.2% | 6,557 | 0.0% | 0.12% | -14.8% |
| Q1 2020 | $532,000 | -6.5% | 6,557 | -3.7% | 0.14% | +9.8% |
| Q4 2019 | $569,000 | -4.4% | 6,807 | 0.0% | 0.12% | -2.4% |
| Q3 2019 | $595,000 | +3.3% | 6,807 | -3.2% | 0.13% | +3.3% |
| Q2 2019 | $576,000 | +0.7% | 7,032 | 0.0% | 0.12% | -19.2% |
| Q1 2019 | $572,000 | +23.5% | 7,032 | 0.0% | 0.15% | +13.5% |
| Q4 2018 | $463,000 | -14.6% | 7,032 | 0.0% | 0.13% | -0.7% |
| Q3 2018 | $542,000 | +45.7% | 7,032 | +39.7% | 0.13% | +32.7% |
| Q2 2018 | $372,000 | +13.8% | 5,032 | 0.0% | 0.10% | +12.2% |
| Q1 2018 | $327,000 | +0.6% | 5,032 | 0.0% | 0.09% | +5.9% |
| Q4 2017 | $325,000 | -31.6% | 5,032 | -33.6% | 0.08% | -34.1% |
| Q3 2017 | $475,000 | +3.5% | 7,575 | 0.0% | 0.13% | -0.8% |
| Q2 2017 | $459,000 | +16.8% | 7,575 | 0.0% | 0.13% | +14.0% |
| Q1 2017 | $393,000 | +57.2% | 7,575 | +34.4% | 0.11% | +46.2% |
| Q4 2016 | $250,000 | -6.7% | 5,638 | 0.0% | 0.08% | -14.3% |
| Q3 2016 | $268,000 | +41.1% | 5,638 | +34.5% | 0.09% | +37.9% |
| Q2 2016 | $190,000 | +9.8% | 4,192 | -0.6% | 0.07% | -14.3% |
| Q1 2016 | $173,000 | +8.1% | 4,218 | +0.6% | 0.08% | +10.0% |
| Q4 2015 | $160,000 | +515.4% | 4,192 | +424.0% | 0.07% | +400.0% |
| Q3 2015 | $26,000 | -55.2% | 800 | -3.3% | 0.01% | -54.8% |
| Q2 2015 | $58,000 | +1.8% | 827 | 0.0% | 0.03% | +3.3% |
| Q1 2015 | $57,000 | – | 827 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |